SEC Form 4 · accession 0001127602-17-025688

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).

Reporting owner

Officer — Corporate Executive VP & CFO

Period of report

Aug 14, 2017

Accepted (ET)

Aug 16, 2017 · 8:02 am EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Aug 14, 2017	S	1,303	$37.8575	D	11,671	D
Common Stock	Aug 14, 2017	M	1,249	$76.12	A	12,920	D
Common Stock	Aug 14, 2017	S	100	$96.98	D	12,820	D
Common Stock	Aug 14, 2017	S	100	$97.20	D	12,720	D
Common Stock	Aug 14, 2017	S	100	$97.29	D	12,620	D
Common Stock	Aug 14, 2017	S	100	$97.31	D	12,520	D
Common Stock	Aug 14, 2017	S	100	$97.37	D	12,420	D
Common Stock	Aug 14, 2017	S	100	$97.43	D	12,320	D
Common Stock	Aug 14, 2017	S	100	$97.63	D	12,220	D
Common Stock	Aug 14, 2017	S	95	$97.73	D	12,125	D
Common Stock	Aug 14, 2017	S	100	$97.76	D	12,025	D
Common Stock	Aug 14, 2017	S	150	$97.88	D	11,875	D
Common Stock	Aug 14, 2017	S	104	$97.97	D	11,771	D
Common Stock	Aug 14, 2017	S	100	$98.47	D	11,671	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)	$76.12	Aug 14, 2017	M	1,249	D	Aug 12, 2016	Aug 12, 2020	Common Stock	1,249	2,498	D